icp-488

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Jul 29, 2022 (NCT05451199)

Timeline

2020s

  1. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06842199Phase 3Feb 28, 2025Beijing InnoCare Pharma Tech Co., Ltd.
NCT06109818Phase 2Oct 30, 2023Beijing InnoCare Pharma Tech Co., Ltd.
NCT05451199Phase 1Jul 29, 2022Beijing InnoCare Pharma Tech Co., Ltd., Chinese Academy of Medical Sciences
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Beijing InnoCare Pharma Tech Co., Ltd.For profit3332022
Chinese Academy of Medical SciencesAcademic/Hospital1012022
2 organizations
Page 1 / 1